{"id":"https://openalex.org/W4396916032","doi":"https://doi.org/10.1080/10428194.2024.2352086","title":"Mitigating time toxicity in lymphoma and multiple myeloma","display_name":"Mitigating time toxicity in lymphoma and multiple myeloma","publication_year":2024,"publication_date":"2024-05-15","ids":{"openalex":"https://openalex.org/W4396916032","doi":"https://doi.org/10.1080/10428194.2024.2352086","pmid":"https://pubmed.ncbi.nlm.nih.gov/38749027"},"language":"en","primary_location":{"id":"doi:10.1080/10428194.2024.2352086","doi":"https://doi.org/10.1080/10428194.2024.2352086","is_oa":false,"landing_page_url":"https://doi.org/10.1080/10428194.2024.2352086","pdf_url":null,"source":{"id":"https://openalex.org/S27064115","display_name":"Leukemia & lymphoma/Leukemia and lymphoma","issn_l":"1026-8022","issn":["1026-8022","1029-2403","1042-8194"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Leukemia & Lymphoma","raw_type":"journal-article"},"volume":null,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5067497285","display_name":"Mengyang Di","orcid":"https://orcid.org/0000-0001-6165-2617","observed_orcids":["https://orcid.org/0000-0001-6165-2617"]},"institutions":[{"id":"https://openalex.org/I201448701","display_name":"University of Washington","ror":"https://ror.org/00cvxb145","country_code":"US","type":"education","lineage":["https://openalex.org/I201448701"]},{"id":"https://openalex.org/I4210089486","display_name":"Fred Hutch Cancer Center","ror":"https://ror.org/007ps6h72","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210089486"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mengyang Di","raw_affiliation_strings":["Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA, USA","Division of Hematology/Oncology, University of Washington, Seattle, WA, USA","Hutchinson Institute for Cancer Outcomes Research, Seattle, WA, USA"],"raw_orcid":"https://orcid.org/0000-0001-6165-2617","affiliations":[{"raw_affiliation_string":"Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA, USA","institution_ids":["https://openalex.org/I4210089486"]},{"raw_affiliation_string":"Division of Hematology/Oncology, University of Washington, Seattle, WA, USA","institution_ids":["https://openalex.org/I201448701"]},{"raw_affiliation_string":"Hutchinson Institute for Cancer Outcomes Research, Seattle, WA, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061376402","display_name":"Christopher T. Su","orcid":"https://orcid.org/0000-0002-2700-2650","observed_orcids":["https://orcid.org/0000-0002-2700-2650"]},"institutions":[{"id":"https://openalex.org/I201448701","display_name":"University of Washington","ror":"https://ror.org/00cvxb145","country_code":"US","type":"education","lineage":["https://openalex.org/I201448701"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Christopher T. Su","raw_affiliation_strings":["Division of Hematology/Oncology, University of Washington, Seattle, WA, USA","Hutchinson Institute for Cancer Outcomes Research, Seattle, WA, USA"],"raw_orcid":"https://orcid.org/0000-0002-2700-2650","affiliations":[{"raw_affiliation_string":"Division of Hematology/Oncology, University of Washington, Seattle, WA, USA","institution_ids":["https://openalex.org/I201448701"]},{"raw_affiliation_string":"Hutchinson Institute for Cancer Outcomes Research, Seattle, WA, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024384857","display_name":"Andrew J. Cowan","orcid":"https://orcid.org/0000-0002-1880-7094","observed_orcids":["https://orcid.org/0000-0002-1880-7094","https://orcid.org/0000-0003-2326-2727"]},"institutions":[{"id":"https://openalex.org/I201448701","display_name":"University of Washington","ror":"https://ror.org/00cvxb145","country_code":"US","type":"education","lineage":["https://openalex.org/I201448701"]},{"id":"https://openalex.org/I4210089486","display_name":"Fred Hutch Cancer Center","ror":"https://ror.org/007ps6h72","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210089486"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Andrew J. Cowan","raw_affiliation_strings":["Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA, USA","Division of Hematology/Oncology, University of Washington, Seattle, WA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA, USA","institution_ids":["https://openalex.org/I4210089486"]},{"raw_affiliation_string":"Division of Hematology/Oncology, University of Washington, Seattle, WA, USA","institution_ids":["https://openalex.org/I201448701"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004025497","display_name":"Ajay K. Gopal","orcid":"https://orcid.org/0000-0003-3023-6834","observed_orcids":["https://orcid.org/0000-0003-3023-6834"]},"institutions":[{"id":"https://openalex.org/I201448701","display_name":"University of Washington","ror":"https://ror.org/00cvxb145","country_code":"US","type":"education","lineage":["https://openalex.org/I201448701"]},{"id":"https://openalex.org/I4210089486","display_name":"Fred Hutch Cancer Center","ror":"https://ror.org/007ps6h72","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210089486"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ajay K. Gopal","raw_affiliation_strings":["Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA, USA","Division of Hematology/Oncology, University of Washington, Seattle, WA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA, USA","institution_ids":["https://openalex.org/I4210089486"]},{"raw_affiliation_string":"Division of Hematology/Oncology, University of Washington, Seattle, WA, USA","institution_ids":["https://openalex.org/I201448701"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5022331310","display_name":"Rahul Kumar Banerjee","orcid":"https://orcid.org/0000-0003-3781-5441","observed_orcids":["https://orcid.org/0000-0003-3781-5441"]},"institutions":[{"id":"https://openalex.org/I201448701","display_name":"University of Washington","ror":"https://ror.org/00cvxb145","country_code":"US","type":"education","lineage":["https://openalex.org/I201448701"]},{"id":"https://openalex.org/I4210089486","display_name":"Fred Hutch Cancer Center","ror":"https://ror.org/007ps6h72","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210089486"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Rahul Banerjee","raw_affiliation_strings":["Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA, USA","Division of Hematology/Oncology, University of Washington, Seattle, WA, USA"],"raw_orcid":"https://orcid.org/0000-0003-3781-5441","affiliations":[{"raw_affiliation_string":"Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA, USA","institution_ids":["https://openalex.org/I4210089486"]},{"raw_affiliation_string":"Division of Hematology/Oncology, University of Washington, Seattle, WA, USA","institution_ids":["https://openalex.org/I201448701"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5022331310"],"corresponding_institution_ids":["https://openalex.org/I201448701","https://openalex.org/I4210089486"],"apc_list":null,"apc_paid":null,"fwci":1.4595,"has_fulltext":false,"cited_by_count":18,"citation_normalized_percentile":{"value":0.82698413,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":93,"max":99},"biblio":{"volume":"65","issue":"10","first_page":"1418","last_page":"1429"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.8314999938011169,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.8314999938011169,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.07000000029802322,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":0.05209999904036522,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/time-toxicity","display_name":"time toxicity","score":0.9959999918937683},{"id":"https://openalex.org/keywords/non-hodgkin-lymphoma","display_name":"non-Hodgkin lymphoma","score":0.9869999885559082},{"id":"https://openalex.org/keywords/multiple-myeloma","display_name":"multiple myeloma","score":1.0},{"id":"https://openalex.org/keywords/follicular-lymphoma","display_name":"follicular lymphoma","score":0.9190000295639038},{"id":"https://openalex.org/keywords/chemoimmunotherapy","display_name":"chemoimmunotherapy","score":0.9459999799728394},{"id":"https://openalex.org/keywords/proteasome-inhibitors","display_name":"proteasome inhibitors","score":0.9670000076293945},{"id":"https://openalex.org/keywords/bisphosphonates","display_name":"bisphosphonates","score":0.996999979019165},{"id":"https://openalex.org/keywords/dosing-regimen","display_name":"dosing regimen","score":0.859000027179718},{"id":"https://openalex.org/keywords/car-t-cell-therapy","display_name":"CAR T-cell therapy","score":0.8640000224113464},{"id":"https://openalex.org/keywords/bispecific-antibodies","display_name":"bispecific antibodies","score":0.9990000128746033},{"id":"https://openalex.org/keywords/clinical-trial-endpoints","display_name":"clinical trial endpoints","score":0.6079999804496765},{"id":"https://openalex.org/keywords/patient-decision-making","display_name":"patient decision-making","score":0.7059999704360962}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7777930498123169},{"id":"https://openalex.org/C2776063141","wikidata":"https://www.wikidata.org/wiki/Q425681","display_name":"Lenalidomide","level":3,"score":0.7768170833587646},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.6977917551994324},{"id":"https://openalex.org/C2776364478","wikidata":"https://www.wikidata.org/wiki/Q467635","display_name":"Multiple myeloma","level":2,"score":0.6822986602783203},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.5642227530479431},{"id":"https://openalex.org/C2777478702","wikidata":"https://www.wikidata.org/wiki/Q419319","display_name":"Bortezomib","level":3,"score":0.5502333045005798},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5493139028549194},{"id":"https://openalex.org/C2777288759","wikidata":"https://www.wikidata.org/wiki/Q4164182","display_name":"Dosing","level":2,"score":0.5040758848190308},{"id":"https://openalex.org/C2777058707","wikidata":"https://www.wikidata.org/wiki/Q123251","display_name":"Follicular lymphoma","level":3,"score":0.46817129850387573},{"id":"https://openalex.org/C2780653079","wikidata":"https://www.wikidata.org/wiki/Q412323","display_name":"Rituximab","level":3,"score":0.46534761786460876},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.46316561102867126},{"id":"https://openalex.org/C2780790343","wikidata":"https://www.wikidata.org/wiki/Q5090610","display_name":"Chemoimmunotherapy","level":4,"score":0.44517478346824646},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4347153306007385}],"mesh":[{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008223","descriptor_name":"Lymphoma","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":false},{"descriptor_ui":"D008223","descriptor_name":"Lymphoma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D008223","descriptor_name":"Lymphoma","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false},{"descriptor_ui":"D008223","descriptor_name":"Lymphoma","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":false},{"descriptor_ui":"D009101","descriptor_name":"Multiple Myeloma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D009101","descriptor_name":"Multiple Myeloma","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016219","descriptor_name":"Immunotherapy, Adoptive","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D016219","descriptor_name":"Immunotherapy, Adoptive","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D019468","descriptor_name":"Disease Management","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D064420","descriptor_name":"Drug-Related Side Effects and Adverse Reactions","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":false},{"descriptor_ui":"D064420","descriptor_name":"Drug-Related Side Effects and Adverse Reactions","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1080/10428194.2024.2352086","doi":"https://doi.org/10.1080/10428194.2024.2352086","is_oa":false,"landing_page_url":"https://doi.org/10.1080/10428194.2024.2352086","pdf_url":null,"source":{"id":"https://openalex.org/S27064115","display_name":"Leukemia & lymphoma/Leukemia and lymphoma","issn_l":"1026-8022","issn":["1026-8022","1029-2403","1042-8194"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Leukemia & Lymphoma","raw_type":"journal-article"},{"id":"pmid:38749027","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/38749027","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Leukemia & lymphoma","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.98580002784729,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":116,"referenced_works":["https://openalex.org/W1132674168","https://openalex.org/W1986297232","https://openalex.org/W1999130958","https://openalex.org/W2019154801","https://openalex.org/W2077941564","https://openalex.org/W2085346499","https://openalex.org/W2103904089","https://openalex.org/W2142368474","https://openalex.org/W2169209759","https://openalex.org/W2529430742","https://openalex.org/W2562306819","https://openalex.org/W2566995909","https://openalex.org/W2593428949","https://openalex.org/W2604776612","https://openalex.org/W2785739259","https://openalex.org/W2805341297","https://openalex.org/W2891543930","https://openalex.org/W2902237589","https://openalex.org/W2904778784","https://openalex.org/W2917537905","https://openalex.org/W2946282972","https://openalex.org/W2946882253","https://openalex.org/W2948728876","https://openalex.org/W2980652063","https://openalex.org/W2984498354","https://openalex.org/W3007925874","https://openalex.org/W3009476682","https://openalex.org/W3019889711","https://openalex.org/W3023211384","https://openalex.org/W3082053425","https://openalex.org/W3104698813","https://openalex.org/W3110979437","https://openalex.org/W3112066866","https://openalex.org/W3126763003","https://openalex.org/W3127065235","https://openalex.org/W3135264042","https://openalex.org/W3136388199","https://openalex.org/W3170038569","https://openalex.org/W3171667648","https://openalex.org/W3185703835","https://openalex.org/W3194859364","https://openalex.org/W3206099201","https://openalex.org/W3212016523","https://openalex.org/W3212279449","https://openalex.org/W4200201081","https://openalex.org/W4200248834","https://openalex.org/W4200626931","https://openalex.org/W4206521392","https://openalex.org/W4206994123","https://openalex.org/W4214862515","https://openalex.org/W4220693451","https://openalex.org/W4220777714","https://openalex.org/W4221025990","https://openalex.org/W4224221896","https://openalex.org/W4281628749","https://openalex.org/W4282033105","https://openalex.org/W4283825270","https://openalex.org/W4284886781","https://openalex.org/W4284987950","https://openalex.org/W4285728919","https://openalex.org/W4291019548","https://openalex.org/W4293356848","https://openalex.org/W4294591656","https://openalex.org/W4295564767","https://openalex.org/W4296042351","https://openalex.org/W4303647690","https://openalex.org/W4307262305","https://openalex.org/W4308189238","https://openalex.org/W4310099115","https://openalex.org/W4310126175","https://openalex.org/W4310126660","https://openalex.org/W4310127434","https://openalex.org/W4311192861","https://openalex.org/W4312072518","https://openalex.org/W4312094698","https://openalex.org/W4312210701","https://openalex.org/W4315435407","https://openalex.org/W4318200489","https://openalex.org/W4319812103","https://openalex.org/W4323352443","https://openalex.org/W4366420841","https://openalex.org/W4366987315","https://openalex.org/W4376131860","https://openalex.org/W4378195388","https://openalex.org/W4378745543","https://openalex.org/W4379280970","https://openalex.org/W4379282426","https://openalex.org/W4379283894","https://openalex.org/W4379338203","https://openalex.org/W4379375856","https://openalex.org/W4379375986","https://openalex.org/W4385070205","https://openalex.org/W4385839624","https://openalex.org/W4386029184","https://openalex.org/W4386287281","https://openalex.org/W4387077574","https://openalex.org/W4388398542","https://openalex.org/W4388572664","https://openalex.org/W4389220105","https://openalex.org/W4389233437","https://openalex.org/W4389243215","https://openalex.org/W4389246660","https://openalex.org/W4389246736","https://openalex.org/W4389247918","https://openalex.org/W4389606680","https://openalex.org/W4390110188","https://openalex.org/W4391070878","https://openalex.org/W4391095371","https://openalex.org/W4391163337","https://openalex.org/W4391601800","https://openalex.org/W4391845134","https://openalex.org/W4391847210","https://openalex.org/W4392093866","https://openalex.org/W4392215371","https://openalex.org/W4392520549","https://openalex.org/W4393074437"],"related_works":["https://openalex.org/W4415738299","https://openalex.org/W4387058038","https://openalex.org/W7108746524","https://openalex.org/W7162098996","https://openalex.org/W4414302567","https://openalex.org/W4401878240","https://openalex.org/W4405039924","https://openalex.org/W4416267011","https://openalex.org/W7213223959","https://openalex.org/W4382983620"],"abstract_inverted_index":{"The":[0],"concept":[1],"of":[2,11,28,53,135],"time":[3,29,47,78,100,133],"toxicity":[4,30,48,79,101,134],"in":[5,31,57,117,121,137],"oncology":[6],"refers":[7],"to":[8,130],"the":[9,51,65,96,125,132],"presence":[10],"frequent":[12],"healthcare-related":[13],"interactions":[14],"that":[15],"can":[16],"interfere":[17],"with":[18,43,98],"patient":[19,114,146],"well-being.":[20],"In":[21,60,74],"this":[22],"review,":[23,126],"we":[24,127],"examine":[25],"several":[26],"manifestations":[27],"non-Hodgkin":[32],"lymphoma":[33,138],"and":[34,37,72,91,120,139],"multiple":[35],"myeloma":[36,140],"discuss":[38,107],"their":[39,143],"impact":[40],"on":[41],"decision-making":[42],"patients.":[44],"For":[45],"example,":[46],"may":[49,63],"influence":[50],"choice":[52],"chemoimmunotherapy":[54],"versus":[55],"lenalidomide-rituximab":[56],"follicular":[58],"lymphoma.":[59],"myeloma,":[61],"it":[62],"inform":[64],"optimal":[66],"dosing":[67],"schedule":[68],"for":[69,113],"proteasome":[70],"inhibitors":[71],"bisphosphonates.":[73],"both":[75,116],"malignancies,":[76],"varying":[77],"profiles":[80],"are":[81],"a":[82,103,111],"key":[83],"distinction":[84],"between":[85],"chimeric":[86],"antigen":[87],"receptor":[88],"T-cell":[89],"therapies":[90,136],"bispecific":[92],"antibodies.":[93],"We":[94],"outline":[95],"challenges":[97],"measuring":[99],"as":[102,110],"trial":[104],"endpoint":[105],"but":[106],"its":[108],"importance":[109],"consideration":[112],"care,":[115],"standard-of-care":[118],"settings":[119],"clinical":[122],"trials.":[123],"Throughout":[124],"highlight":[128],"strategies":[129],"lower":[131],"without":[141],"compromising":[142],"efficacy":[144],"or":[145],"safety.":[147]},"counts_by_year":[{"year":2026,"cited_by_count":9},{"year":2025,"cited_by_count":7},{"year":2024,"cited_by_count":2}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2024-05-16T00:00:00"}